Lv11
42 积分 2026-08-16 加入
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
1小时前
待确认
Metabolic-related gene signatures for survival prediction and immune cell subtypes associated with prognosis in intrahepatic cholangiocarcinoma
1小时前
已完结
Dipeptidyl peptidase 4 inhibition sensitizes radiotherapy by promoting T cell infiltration
1小时前
已完结
DNA Methylation of Cannabinoid Receptor Interacting Protein 1 Promotes Pathogenesis of Intrahepatic Cholangiocarcinoma Through Suppressing Parkin‐Dependent Pyruvate Kinase M2 Ubiquitination
2小时前
已完结
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
2小时前
已完结
Cholangiocarcinoma
1个月前
已完结
The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers
1个月前
已完结
Cryoablation induces abscopal immunity in intrahepatic cholangiocarcinoma
2个月前
已完结
Immunology and immunotherapy of cholangiocarcinoma
2个月前
已完结
皖公网安备34019202002308
